The "Halftime Report" traders discussed their game plan for the remainder of the trading day.

Douglas C. Lane & Associates Managing Director Sarat Sethi liked MYL and PRGO. Mylan offered nearly $29 billion yesterday for rival generic drugmaker Perrigo.